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Surgical implications of early failed endovascular
intervention of the superficial femoral artery
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Eugene M. Langan III, MD, and Spence M. Taylor, MD, Greenville, SC
Background: It is generally accepted that failed infrainguinal bypass with prosthetic material significantly compromises
arterial run off, which may limit future revascularization. It is well known that the negative consequences of early vein
graft thrombosis are limited, but the effect of failed peripheral angioplasty on the distal vasculature is poorly studied. The
purpose of this study was to determine whether early failure after superficial femoral artery intervention influences
subsequent revascularization options.
Methods: Between July 1, 1998, and June 30, 2006, 276 patients underwent endovascular intervention of the superficial
femoral artery. A prospective analysis of angiograms done before the intervention and after early failure (<200 days) was
performed in a blinded fashion by three attending vascular surgeons to determine the optimal distal bypass site if an
operation were to be performed. Inter-rater reliability of the angiogram scores was assessed using the Fleiss generalized
 for multiple raters. Potential distal anastomotic sites were classified as above knee popliteal, below knee popliteal, tibial,
or no adequate site. A consensus classification was determined for each patient (2 of 3 raters).
Results: Of the 276 patients who underwent endovascular intervention of the superficial femoral artery, early failure was
noted in 24 limbs in 23 patients. Angiographic records were available for 21 limbs in 20 patients (60% men; mean age,
65.3  11.3 years), of which 60% had critical limb ischemia, 40% had claudication, and 65% had diabetes. The distal
bypass site was altered in six limbs (28.6%); four from popliteal to tibial and two from above knee to below knee popliteal.
Inter-rater reliability was 0.54 (moderate/good). The procedures performed on these early failures were percutaneous
transluminal angioplasty stent (n 14), infrainguinal bypass (n 5), and no treatment (n 1). Only 0.4% (1 of 276)
of patients required major limb amputation due to early failure of a superficial femoral artery intervention.
Conclusions: Early failure after isolated endovascular intervention of the superficial femoral artery is infrequent and alters
the distal target in 30% of early-failure patients if open bypass is planned. Salvage with repeat angioplasty, if necessary, can
be accomplished in most patients, and the need for limb amputation is exceedingly rare. The early failure results in this
study support a more liberal application of endovascular intervention to the superficial femoral artery in patients with
lower extremity ischemia, especially claudication. The repercussions of late endovascular failure as well as the effects of
disease progression need further study. (J Vasc Surg 2008;47:562-5.)Many surgeons are hesitant to operate on claudication
because of its relatively benign clinical course and the
concern that bypass failure can result in a clinical problem
more severe than the initial presentation. Endovascular
therapy for lower extremity ischemia has experienced in-
creased popularity within the past two decades owing to its
favorable risk/benefit ratio and the appreciation that pa-
tients without autogenous conduit can be revascularized
and avoid the infection risks of synthetic grafts.1-5
The benefits of endovascular intervention include a
minimally invasive, percutaneous approach, shorter patient
hospital stay, and earlier patient return to normal activi-
ties.2,6-9 Long-term patency of angioplasty is inferior to
bypass, however, and the subsequent consequences of
failed angioplasty are unclear. The few studies that have
examined treatment options and outcomes after endovas-
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562cular failure provide conflicting evidence. Some studies
suggest that future revascularization options are altered and
subsequent bypass results are worse than expected after
failed endovascular therapy; others report no detrimental
anatomic effects on future revascularization.10-14
The purpose of this study is to evaluate the anatomic
effects of early failure after isolated endovascular interven-
tion of the superficial femoral artery and to examine the
need for, and outcome of, subsequent revascularization.
METHODS
The prospective vascular database of the Greenville
Hospital System University Medical Center showed that
between July 1, 1998, and June 30, 2006, 276 patients
underwent isolated endovascular intervention of the super-
ficial femoral artery; 154 were for claudication, and 122
were for critical limb ischemia (CLI). Technical or clinical
failure200 days of intervention was identified in 23 limbs
in 23 patients and defined as an early failure. Of these, 21
limbs in 20 patients were evaluated with arteriography and
were available for follow-up. Limbs presented with either
symptoms of ischemia requiring reintervention (n 19), a
clinical suspicion and arteriographic confirmation of super-
ficial femoral artery restenosis (n  1), or severe ischemia
requiring major limb amputation (n  1). The mean
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137-2171 days); no patients in this group were lost to
follow-up.
In the early-failure patients, all but one endovascular
procedure was performed in a fixed interventional suite
within the operating room or radiology department. Access
was obtained through the contralateral common femoral
artery in a retrograde fashion when possible. Stenosis and
occlusion were traversed intraluminally in most cases. Two
of the initial revascularizations were performed with subin-
timal techniques. Laser-assisted angioplasty (n  3) and
cryotherapy (n  1) were used sparingly. Two patients
underwent thrombolysis before the initial revasculariza-
tion. The follow-up interval and modality was at the discre-
tion of the primary vascular attending, with typical practice
being every 3 months with arterial duplex ultrasound im-
aging and ankle-brachial indices.
A prospective study was performed to examine the
impact of angioplasty failure on the distal run off beds of the
affected limbs. The preintervention and postfailure arterio-
grams were analyzed by three attending vascular surgeons
in a blinded fashion to determine the distal bypass targets
most suitable for distal anastomosis if bypass were to be
performed. The distal anastomotic sites were classified as
above knee (AK) popliteal, below knee (BK) popliteal, or
tibial. If the chosen target was not unanimous, the consen-
sus choice (2 of 3) was used. Inter-rater reliability of the
angiogram scores was assessed using the Fleiss generalized
 for multiple raters.
Clinical outcome for patients who underwent reinter-
vention was examined using the vascular registry database.
Life-table analysis was used to estimate survival functions
for the time dependent outcomes of secondary patency,
limb loss, death, and amputation-free survival. The differ-
ences in the curves were assessed using the log-rank test. All
statistical measures were performed using SAS 9.1.3 soft-
ware (SAS Institute, Cary, NC).
RESULTS
Early failure occurred in only 23 of the 276 patients
(8.3%) receiving isolated endovascular intervention of the
superficial femoral artery. Of the 21 limbs in 20 patients
available for follow-up, 19 limbs received reintervention.
The mean time to reintervention was 134 days (range,
98-197 days). Demographics for the patients with failed
angioplasty are listed in the Table. The clinical indication
for repeat angiography was claudication for nine limbs and
CLI for the other 12. Two limbs presented with indications
that differed from the original presentation. In one claudi-
cant patient, stent occlusion resulted in rest pain and the
patient underwent successful bypass to the BK popliteal
artery. A single patient with CLI (rest pain) with an initial
occlusion of the superficial femoral artery returned with
claudication after development of in-stent restenosis and
was treated with repeat percutaneous transluminal angio-
plasty (PTA) and a stent.
Preintervention angiographic findings included 14 oc-
clusions and seven stenoses. Postfailure arteriographic find-ings showed 11 occlusions and 10 stenotic lesions. Blinded
angiographic analysis of distal anastomotic target sites by
the three vascular surgeon judges resulted in unanimous
agreement in 12 cases and majority agreement in nine for a
 of 0.54 for inter-rater reliability, considered moderate/
good agreement. After analysis, the optimal distal anas-
tomotic site was altered in six limbs (28.6%). The prein-
tervention and postfailure Trans-Atlantic Inter-Society
Consensus (TASC) classification for the superficial fem-
oral artery lesions are shown in Fig 1.15 There were no
TASC D lesions. The area of intervention was limited to
the superficial femoral artery and if necessary extended into
the AK popliteal artery. No initial interventions crossed the
knee joint.
The preintervention and postfailure distal bypass tar-
Fig 1. A, TransAtlantic Inter-Society Consensus (TASC) classi-
fications of lesions before the initial intervention. B, TASC classi-
fications after early failure.
Demographic and clinical information for 20 patients
with early failure after superficial femoral artery
angioplasty
Demographic Value
Age, mean  SD years 65.3  11.3
Male, No. (%) 12 (60)
Critical limb ischemia, No. (%) 12 (60)
Claudication, No. (%) 8 (40)
Tobacco Use, No. (%) 14 (70)
Diabetes, No. (%) 13 (65)
End-stage renal disease, No. (%) 3 (15)
Time to failure, mean (range) days 134 (77-194)gets are shown graphically in Fig 2. The TASC classification
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limbs, and improved in four compared with the initial
lesions. Only one patient with an altered distal target pre-
sented with a more extensive TASC lesion (TASC A to
TASC B). The optimal distal bypass target changed from
the AK popliteal artery to the tibial artery in two limbs,
from the BK popliteal artery to the tibial artery in two
limbs, and from the AK popliteal artery to the BK popliteal
artery in two limbs. Half of the limbs with distal anasto-
motic site alteration (3 of 6) developed occlusion in one
runoff vessel. This occurred in only one limb (6.7%) with-
out target alteration.
When clinical factors associated with alteration of the
distal target site were examined, including age, sex, race,
diabetes, indication for intervention, occlusive vs stenotic
atherosclerotic lesion, and the use of a stent with the initial
intervention, no factor was predictive of distal target site
alteration. Although not statistically significant, patients
who presented initially with CLI at the time of their super-
ficial femoral artery angioplasty were more likely to have a
change in the optimal distal anastomotic bypass site to a
more distal location after failure than patients who pre-
sented with claudication (41.7% vs 11.1%, P  .18). Like-
wise, 36.4% of patients who presented with occlusions
experienced distal anastomotic site alteration compared
with 20% of patients with stenotic lesions, a difference that
did not reach statistical significance.
Despite early interventional failure, salvage with repeat
endovascular intervention (PTA in 2, PTA/stent in 12) was
possible in 14 limbs (67%). An additional five limbs (23.8%)
underwent infrainguinal bypass, one limb did not require
repeat intervention, and one limb required major limb
amputation secondary to severe infection after repeat PTA/
stent. All five secondary bypasses were performed for CLI
and included femoral to AK popliteal (n  1), femoral to
BK popliteal (n  3), and femoral to tibial (n  1) bypass.
In general, patients receiving secondary intervention
after initial superficial femoral artery angioplasty failure
fared well. Secondary patency was 58% at 60 months for
patients with CLI and 89% for claudicant patients. Second-
ary patency (80% vs 50%) and limb salvage (86% vs 40%)
were better at 60 months for patients without alteration in
the distal anastomotic site; however, this too was not
Fig 2. Optimal distal anastomotic sites before intervention and
after early failure. AK, above knee; BK, below knee.statistically significant.DISCUSSION
Endovascular techniques have become an accepted op-
tion for the treatment of lower extremity ischemia in many
centers. Patients with and without bypass options often
undergo initial attempts at endovascular revascularization
before surgical therapy. Results for intervention vary by
site. Distal lesions have less durable results but are being
performedwith increasing frequency, thusmaking the need
for future reintervention more likely.13,16-19 Recognizing
the implications of selecting an endovascular procedure for
revascularization is important, particularly if the procedure
could adversely effect future treatment options.
Our results differ dramatically from the results of Böckler
et al,10 who studied 25 consecutive patients presenting
with failed infrainguinal angioplasty with primary stenting
for claudication in 19 or CLI in six. All but one patient in
their study presented with CLI after endovascular failure,
and 88% presented with stent occlusions. Repeat interven-
tions for the patients in the Böckler et al series included 16
bypass grafts, 4 endarterectomies, 3 amputations, and 1
sympathectomy. The 12-month patency for bypass after
endovascular failure was dramatically worse than for a co-
hort of patients undergoing primary bypass (33% vs 88%).10
Ryer et al11 andGalaria et al13 describe results similar to
those found in our study, although they did not provide
anatomic details about the distal vasculature. Postfailure
bypass level and distal anastomotic site were not altered in
either study. In the study by Ryer et al, however, repeat
endovascular intervention was performed in 83% of endo-
vascular failures, and postfailure bypass was more common
in the study by Galaria et al. An interesting study by Lipsitz
et al14 addressed the regional anatomic effects of endovas-
cular intervention. They noted that most collateral vessels
in the region of intervention are preserved after subintimal
angioplasty.14 The preservation of collaterals suggests a
limit to the ischemic repercussions if occlusion recurs,
although this was not directly examined in their study.
Early failure after isolated intervention of the superficial
femoral artery is uncommon in our experience, occurring in
less than 9% of patients. Most patients return with clinical
findings similar to their first presentation. Two-thirds of the
patients in this study with early failure were treated with
endovascular techniques, with an overall secondary patency
rate of 79% at 1 year. When failure occurs, it alters the distal
bypass target in 28% of cases. Restenosis typically occurs
within the area of the superficial femoral artery that has
been previously treated, leaving the distal anatomy pre-
served. Significant embolization to the distal runoff or
long, progressive occlusions were not identified as the
source of failure; however, the runoff vessels were altered in
half of the limbs with distal anastomotic site alteration,
which is much higher than in the nonaltered patients.
Before intervention, significant efforts are made to identify
intraluminal thrombus. In patients with occlusion, our
standard technique is a “wire traversal test” to observe the
passage characteristics of the wire. Easy passage with mini-
mal resistance suggests thrombotic occlusion, and these
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ysis, or both, before angioplasty.
The indication for intervention and the initial lesion
appear to affect the repercussions of early endovascular
failure, but the use of stents does not. Only one patient had
stent placement into the AK popliteal artery, directly elim-
inating that site as a bypass site. Although small numbers
prevent statistical confirmation, patients with CLI were
more likely to have migration of the distal bypass site than
those with claudication (41.7% vs 11.1%). The incidence of
distal target site alteration was equivalent in patients with
initial PTA or PTA/stent (28.6%). The distal anastomotic
site was altered in 36.4% of patients presenting with occlu-
sions and only 20% of patients with stenotic lesions. Be-
cause most of the patients in the study by Böckler et al
recurred with occlusion, this may be the reason their pa-
tients appear to have worse outcomes.
The small patient sample size does place limitations on
this study, and makes a type II error likely, especially when
comparing patients according to indications for interven-
tion. However, this is also a sign of the durability of
superficial femoral artery intervention, given the early fail-
ure rate of only 8.3% in this study.
CONCLUSION
Early failure after endovascular intervention of the su-
perficial femoral artery alters future bypass options in 30%
of patients. Most early recurrent lesions are similar to or less
extensive than the initial lesion when comparing the TASC
classification and the degree of stenosis. Repeat endovascu-
lar intervention can be considered before using open surgi-
cal techniques for these early-failure patients, resulting in
acceptable limb salvage. However, endovascular interven-
tion should be considered with more caution in CLI pa-
tients with limited conduit because distal target alteration
seems to be more likely in these patients and could result in
a less than optimal bypass if early failure occurs. In contrast,
the findings in this study support a liberal application of
endovascular intervention to the superficial femoral artery
in patients with claudication in regards to early failure.
Additional studies are needed to assess the repercussions of
delayed endovascular failure in terms of symptoms, anat-
omy, and future revascularization options.
AUTHOR CONTRIBUTIONS
Conception and design: CJ, CK, JY, ST, DC, EL
Analysis and interpretation: CJ, JY, ST, DC
Data collection: CJ, CK
Writing the article: CJ, JY, DC, ST
Critical revision of the article: CJ, JY, ST
Final approval of the article: CJ, JY
Statistical analysis: CK
Obtained funding: Not applicable
Overall responsibility: CJREFERENCES
1. Sullivan TM, Taylor SM, Blackhurst DW, Langan EM 3rd, Cull DL,
Carsten CG 3rd, et al. Has endovascular surgery reduced the number of
open vascular operations performed by an established surgical practice?
J Vasc Surg 2002;36:514-9.
2. Kudo T, Chandra FA, Kwun WH, Haas BT, Ahn SS. Changing pattern
of surgical revascularization for critical limb ischemia over 12 years:
endovascular vs. open bypass surgery. J Vasc Surg 2006;44:304-13.
3. Haider SN, Kavanagh EG, Forlee M, Colgan MP, Madhavan P, Moore
DJ, et al. Two-year outcome with preferential use of infrainguinal
angioplasty for critical ischemia. J Vasc Surg 2006;43:504-12.
4. Anderson PL, Gelijns A, Moskowitz A, Arons R, Gupta L, Weinberg A,
et al. Understanding trends in inpatient surgical volume: vascular inter-
ventions, 1980-2000. J Vasc Surg 2004;39:1200-8.
5. Hallett JW Jr, Byrne J, Gayari MM, Ilstrup DM, Jacobsen SJ, Gray DT.
Impact of arterial surgery and balloon angioplasty on amputation: a
population-based study of 1155 procedures between 1973 and 1992. J
Vasc Surg 1997;25:29-38.
6. Wolf GL, Wilson SE, Cross AP, Deupree RH, Stason WB. Surgery or
balloon angioplasty for peripheral vascular disease: a randomized clinical
trial. Principal investigators and their Associates of Veterans Adminis-
tration Cooperative Study Number 199. J Vasc Interv Radiol 1993;4:
639-48.
7. Holm J, Arfvidsson B, Jivegard L, Lundgren F, Lundholm K, Schersten
T, et al. Chronic lower limb ischaemia. A prospective randomised
controlled study comparing the 1-year results of vascular surgery and
percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg 1991;5:
517-22.
8. AdamDJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al.
Bypass versus angioplasty in severe ischaemia of the leg (BASIL):
multicentre, randomised controlled trial. Lancet 2005;366:1925-34.
9. Dosluoglu HH, O’Brien-Irr MS, Lukan J, Harris LM, Dryjski ML,
Cherr GS. Does preferential use of endovascular interventions by vas-
cular surgeons improve limb salvage, control of symptoms, and survival
of patients with critical limb ischemia? Am J Surg 2006;192:572-6.
10. Bockler D, Blaurock P, Mansmann U, Schwarzbach M, Seelos R,
Schumacher H, et al. Early surgical outcome after failed primary stent-
ing for lower limb occlusive disease. J Endovasc Ther 2005;12:13-21.
11. Ryer EJ, Trocciola SM, DeRubertis B, LamR,Hynecek RL, Karwowski
J, et al. Analysis of outcomes following failed endovascular treatment of
chronic limb ischemia. Ann Vasc Surg 2006;20:440-6.
12. Sandford RM, Bown MJ, Sayers RD, London JN, Naylor AR, McCarthy
MJ. Is infrainguinal bypass grafting successful following failed angioplasty?
Eur J Vasc Endovasc Surg 2007;34:29-34.
13. Galaria II, Davies MG. Percutaneous transluminal revascularization for
iliac occlusive disease: long-term outcomes in TransAtlantic Inter-
Society Consensus A and B lesions. Ann Vasc Surg 2005;19:352-60.
14. Lipsitz EC, Ohki T, Veith FJ, Rhee SJ, Kurvers H, Timaran C, et al.
Fate of collateral vessels following subintimal angioplasty. J Endovasc
Ther 2004;11:269-73.
15. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes
FG. Inter-Society Consensus for the management of peripheral arterial
disease (TASC II). J Vasc Surg 2007;45(suppl S):S5-67.
16. Kudo T, Chandra FA, Ahn SS. Long-term outcomes and predictors of
iliac angioplasty with selective stenting. J Vasc Surg 2005;42:466-75.
17. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, et al.
Drug-eluting and bare nitinol stents for the treatment of atherosclerotic
lesions in the superficial femoral artery: long-term results from the
SIROCCO trial. J Endovasc Ther 2006;13:701-10.
18. Surowiec SM, Davies MG, Eberly SW, Rhodes JM, Illig KA, Shortell
CK, et al. Percutaneous angioplasty and stenting of the superficial
femoral artery. J Vasc Surg 2005;41:269-78.
19. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al.
Balloon angioplasty versus implantation of nitinol stents in the superfi-
cial femoral artery. N Engl J Med 2006;354:1879-88.Submitted Jul 23, 2007; accepted Nov 12, 2007.
